Grant: Catalyst Grant: Sex as a Variable in Biomedical Research
Université Laval
$150,000.00
The role of sex in regulating interleukin-17-mediated toxicity in the central nervous system.
FY 2017-18
Summary
Multiple sclerosis (MS) is a chronic disease in which the immune system attack and destroy cells in the brain and spinal cord. While there are a number of drugs that can help relieve symptoms in the early "relapsing/remitting" phase of MS, treatment option in the late "secondary progressive" phase are very limited. While women develop MS more frequently than men, the progression of symptoms occurs more rapidly in men. Understanding the role played by sex in MS could help us develop better therapies.
In our lab, we study a variant of MS in mice. We find that male mice get worse disease and in fact develop secondary progressive symptoms. In this grant, we will try and understand why this is the case.
Increased disease in male mice could be due to two possible reasons: either immune cells are more easily able to enter the brain/spinal cord and are more potent than in females, or the cells that make up the male brain and spinal cord are more sensitive to immune attack. We will therefore try to distinguish between these possibilities.
Sex differences are often considered to be the result of sex hormones, ie. due to the fact that males produce testosterone and females produce estrogen and progesterone. However, this overlooks the fact that men and women have one chromosome that is entirely different. We will therefore use a unique genetically engineered mouse strain whose pups can uncouple sex hormones from sex chromosomes. These "4 core genotype" mice can have testes with XY chromosomes; testes with XX chromosomes; ovaries with XY; or ovaries with XX. We will examine each of these mice for their ability to develop secondary progressive symptoms.
This project is important because it will help us understand why men and women show such striking differences in MS. In the future, this could help us to predict whether one sex can respond better to a given MS drug than another. This will in turn help neurologists make more informed decisions regarding MS patient care.
Department
Program
Catalyst Grant: Sex as a Variable in Biomedical Research
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
377879
Name
Rangachari Manu
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Catalyst Grant: Sex as a Variable in Biomedical or Translational Research
Projecttitle
The role of sex in regulating interleukin-17-mediated toxicity in the central nervous system.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Sex as a Variable in Biomedical Research
Keyworddelim
Central Nervous System; Experimental Autoimmune Encephalomyelitis; Flow Cytometry; Histopathology; Interleukin-17; Multiple Sclerosis; Sex Differences; T Cells
Abstract
Multiple sclerosis (MS) is a chronic disease in which the immune system attack and destroy cells in the brain and spinal cord. While there are a number of drugs that can help relieve symptoms in the early "relapsing/remitting" phase of MS, treatment option in the late "secondary progressive" phase are very limited. While women develop MS more frequently than men, the progression of symptoms occurs more rapidly in men. Understanding the role played by sex in MS could help us develop better therapies.
In our lab, we study a variant of MS in mice. We find that male mice get worse disease and in fact develop secondary progressive symptoms. In this grant, we will try and understand why this is the case.
Increased disease in male mice could be due to two possible reasons: either immune cells are more easily able to enter the brain/spinal cord and are more potent than in females, or the cells that make up the male brain and spinal cord are more sensitive to immune attack. We will therefore try to distinguish between these possibilities.
Sex differences are often considered to be the result of sex hormones, ie. due to the fact that males produce testosterone and females produce estrogen and progesterone. However, this overlooks the fact that men and women have one chromosome that is entirely different. We will therefore use a unique genetically engineered mouse strain whose pups can uncouple sex hormones from sex chromosomes. These "4 core genotype" mice can have testes with XY chromosomes; testes with XX chromosomes; ovaries with XY; or ovaries with XX. We will examine each of these mice for their ability to develop secondary progressive symptoms.
This project is important because it will help us understand why men and women show such striking differences in MS. In the future, this could help us to predict whether one sex can respond better to a given MS drug than another. This will in turn help neurologists make more informed decisions regarding MS patient care.
Competitiondate
201711
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Rangachari, Manu
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Gender & Health~ $150,000~ $0~